跳至主要内容
临床试验/NCT02260219
NCT02260219终止不适用

Comparative Study of the Safety and Efficacy of the Ahmed Glaucoma Valve Drainage Device, Model M4 (High Density Porous Polyethylene) and the Model S2 (Polypropylene) in Patients With Neovascular Glaucoma

Asociación para Evitar la Ceguera en México0 个研究点目标入组 42 人开始时间: 2012年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
发起方
入组人数
42
主要终点
Number of participants with adverse effects

研究概览

简要总结

Objective: Prospectively evaluate the safety and efficacy of the Ahmed Glaucoma Drainage Device, model M4 compared with the model S2.

Method: Mexican patients with Neovascular Glaucoma will be randomly included for each group (M4 and S2). They will be operated using conventional techniques and creating a sub-episcleral tunnel to place the valve's tube in the anterior chamber. They will be monitoring for one year and the results will be evaluated with respect to a postoperative reduction in pressure, changes in visual acuity, the need for drugs and complications, in addition to the demographic characteristics of each group.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with diagnosis of Neovascular glaucoma
  • High IOP despite topical treatment

排除标准

  • Pregnant women
  • Mental disorders
  • Previous glaucoma surgery
  • Patients older than 18 years

研究组 & 干预措施

S2

Active Comparator

Surgically Implant an Ahmed Glaucoma Drainage Device Model S2 in Neovascular Glaucoma Patients and evaluate the IOP evolution, complications and need for medication to control IOP

干预措施: Surgical Implant of Ahmed Glaucoma Drainage Device, model M4 and S2 (Procedure)

M4

Active Comparator

Surgically Implant an Ahmed Glaucoma Drainage Device Model M4 in Neovascular Glaucoma Patients and evaluate the IOP evolution, complications and need for medication to control IOP

干预措施: Surgical Implant of Ahmed Glaucoma Drainage Device, model M4 and S2 (Procedure)

结局指标

主要结局

Number of participants with adverse effects

时间窗: 1 year

次要结局

  • Intraocular pressure(1 year)

研究者

发起方
Asociación para Evitar la Ceguera en México
申办方类型
Other
责任方
Sponsor

相似试验